title: Ozone therapy ameliorates tubulointerstitial inflammation by regulating TLR4 in adenine-induced CKD rats.
abstract: Tubulointerstitium inflammation is a common pathway aggravating chronic kidney disease (CKD) progression and the mechanism is partly associated with excessive activation of toll-like receptor 4 (TLR4) in tubulointerstitium. Ozone therapy is demonstrated to alleviate inflammation in some experiments. The aim of this study is to examine whether ozone therapy could ameliorate chronic tubulointerstitium inflammation by suppressing TLR4 in adenine-induced CKD rats. Sprague-Dawley rats were fed with 0.75% adenine-containing diet to induce CKD and tubulointerstitium inflammation injury. Ozone therapy (1.1 mg/kg) was simultaneously administrated by rectal insufflations (i.r.). After 4 weeks, serum and kidney samples were collected for detection. Renal function and systemic electrolyte were detected. Renal pathological changes were assessed by hematoxylin-eosin (H&E) staining and Masson trichrome (MT) staining. Immunohistochemistry, Western blot and Real-time PCR were applied to evaluate tubulointerstitium inflammation as well as the expression of TLR4 and phosphorylated nuclear factor kappa B P65 (p-NF-κB P65) in rats. The results showed ozone therapy improved serious renal insufficiency, systemic electrolyte disorder and tubulointerstitium morphology damages in adenine-induced CKD rats. In addition, ozone therapy suppressed excessive activation of TLR4 and p-NF-κB P65 in the tubulointerstitium of adenine-induced CKD rats, accompanied by the reduction of inflammation-related cytokines including monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6). The protein expression of TLR4 was positively correlated with the protein expression levels of MCP-1 (r = 0.7863, p < 0.01) and TNF-α (r = 0.7547, p < 0.01) in CKD rats. These findings indicated ozone therapy could attenuate tubulointerstitium inflammation injury in adenine-induced CKD rats and the mechanism might associate with the mediation of TLR4.
authors.affiliation: a Department of Urology , Renmin Hospital of Wuhan University , Wuhan, Hubei Province , P.R. China.
authors.forename: Zhiyuan
authors.initials: Z
authors.lastname: Chen
authors.affiliation: a Department of Urology , Renmin Hospital of Wuhan University , Wuhan, Hubei Province , P.R. China.
authors.forename: Xiuheng
authors.initials: X
authors.lastname: Liu
authors.affiliation: a Department of Urology , Renmin Hospital of Wuhan University , Wuhan, Hubei Province , P.R. China.
authors.forename: Gang
authors.initials: G
authors.lastname: Yu
authors.affiliation: a Department of Urology , Renmin Hospital of Wuhan University , Wuhan, Hubei Province , P.R. China.
authors.forename: Hui
authors.initials: H
authors.lastname: Chen
authors.affiliation: a Department of Urology , Renmin Hospital of Wuhan University , Wuhan, Hubei Province , P.R. China.
authors.forename: Lei
authors.initials: L
authors.lastname: Wang
authors.affiliation: a Department of Urology , Renmin Hospital of Wuhan University , Wuhan, Hubei Province , P.R. China.
authors.forename: Zhishun
authors.initials: Z
authors.lastname: Wang
authors.affiliation: a Department of Urology , Renmin Hospital of Wuhan University , Wuhan, Hubei Province , P.R. China.
authors.forename: Tao
authors.initials: T
authors.lastname: Qiu
authors.affiliation: a Department of Urology , Renmin Hospital of Wuhan University , Wuhan, Hubei Province , P.R. China.
authors.forename: Xiaodong
authors.initials: X
authors.lastname: Weng
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D018450:Disease Progression; D007150:Immunohistochemistry; D007249:Inflammation / Q000378:metabolism; D007668:Kidney / Q000378:metabolism / Q000473:pathology; D007677:Kidney Function Tests / Q000379:methods; D016328:NF-kappa B / Q000378:metabolism; D010083:Oxidants, Photochemical / Q000494:pharmacology; D010126:Ozone / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D051436:Renal Insufficiency, Chronic / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy; D051197:Toll-Like Receptor 4 / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D016328:NF-kappa B; D010083:Oxidants, Photochemical; C495347:Tlr4 protein, rat; D051197:Toll-Like Receptor 4; D010126:Ozone
keywords: Adenine; ozone therapy; rat; toll-like receptor 4; tubule-interstitial inflammation